Hem › Bröstcancer › North Carolina › Durham
Kliniska studier för Bröstcancer i Durham, NC
64 studier för Bröstcancer söker deltagare vid platser i och runt Durham (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekryterarFriska volontärer välkomna
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
A Study of PHST001 in Advanced Solid Tumors
RekryterarFas 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekryterarFas 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
RekryterarFas 2Friska volontärer välkomna
- University of North Carolina, Chapel Hill · 10 mi bort
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekryterarFas 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · 10 mi bort
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
RekryterarObservationsstudie
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
RekryterarFas 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
RekryterarObservationsstudieFriska volontärer välkomna
- University of North Carolina, Chapel Hill · 10 mi bort
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekryterarFas 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekryterarFas 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekryterarFas 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekryterarFas 3
- University of North Carolina Medical Center, Chapel Hill · 10 mi bort
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RekryterarFas 2
- University of North Carolina Medical Center, Chapel Hill · 10 mi bort
Identifying Patterns in the Breath of Individuals With Breast Cancer
RekryterarObservationsstudieFriska volontärer välkomna
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
RekryterarFas 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi bort
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
RekryterarFas 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi bort
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekryterarFas 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
RekryterarObservationsstudie
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi bort
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RekryterarFas 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekryterarFas 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
RekryterarFas 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekryterarFas 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
RekryterarFas 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
RekryterarFas 2
- University of North Carolina, Chapel Hill · 10 mi bort
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekryterarFas 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
- University of North Carolina-Hillsborough Campus, Hillsborough · 13 mi bort
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
RekryterarFriska volontärer välkomna
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
RekryterarFas 2
- University of North Carolina, Chapel Hill · 10 mi bort
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Rekryterar
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
RekryterarObservationsstudie
- University of North Carolina, Chapel Hill · 10 mi bort
Weight Management After Cancer for Survivors in Rural Communities
Rekryterar
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
Rekryterar
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekryterarFas 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Rekryterar
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
RekryterarFas 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
Rekryterar
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
RekryterarFas 1
- University of North Carolina, Chapel Hill · 10 mi bort
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Rekryterar
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi bort
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Rekryterar
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
RekryterarObservationsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi bort
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
RekryterarFas 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
RekryterarFas 1
- University of North Carolina, Chapel Hill · 10 mi bort
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
RekryterarFas 2Friska volontärer välkomna
- The University of North Carolina, Chapel Hill · 10 mi bort
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
RekryterarObservationsstudie
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi bort
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
RekryterarFas 2
- University of North Carolina, Chapel Hill · 10 mi bort
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Rekryterar
- University of North Carolina, Chapel Hill · 10 mi bort
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
RekryterarFas 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi bort
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RekryterarFas 2
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi bort
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
RekryterarFas 2
- University of North Carolina, Chapel Hill · 10 mi bort
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
RekryterarFas 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Rekryterar
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RekryterarFas 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
RekryterarObservationsstudie
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
RekryterarFas 2
- University of North Carolina, Chapel Hill · 10 mi bort
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekryterarFas 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Rekryterar
- UNC Cancer Hospital, Chapel Hill · 10 mi bort
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Rekryterar
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Rekryterar
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Rekryterar
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · 10 mi bort
BREAST Choice Decision Tool R21 - AIM2
RekryterarFriska volontärer välkomna
- The University of North Carolina, Chapel Hill · 10 mi bort
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Rekryterar
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi bort
UNC Pleural Fluid Registry
RekryterarObservationsstudie
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mi bort
Bröstcancer-studier i andra städer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
- Arlington, VA47 studier
Andra studier i Durham
- Cancer (alla typer)58 studier
- Icke-småcellig lungcancer39 studier
- Multipelt myelom37 studier
- Akut myeloid leukemi33 studier
- Metastaserande cancer33 studier
- Prostatacancer32 studier
- Lungcancer32 studier
- Kolorektal cancer28 studier
- Äggstockscancer27 studier
- Kronisk lymfatisk leukemi27 studier
- Hjärtsvikt26 studier
- Bukspottkörtelcancer24 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.